Autism, Male, 8 years, September – October 2023

Summary

Diagnosis Sex Age Nationality
Autism Male 8 years Australia
Injections Cell type Admission date Discharge date
8 UCMSC September 17th 2023 October 1st 2023

Medical history

The patient, born in 2015, has a primary diagnosis of Autism Spectrum Disorder (ASD) at level 3, accompanied by non-verbal tendencies, diagnosed in March 2018. Intensive therapeutic interventions, including 20 hours per week of speech therapy, occupational therapy, ABA, and Early Start Denver Model, were conducted between 2019 and 2021, with no medications administered for the ASD diagnosis.

Condition On Admission

The patient’s primary ASD symptoms are non-verbal communication and frequent self-stimulatory behaviors. Additionally, the patient experiences chronic constipation, managed daily with a natural laxative, with symptoms beginning around age 2.5. The patient also has nut allergies, specifically to cashews and pistachios, causing allergic reactions. The patient’s family aims for improved awareness, healing, and potential speech development as the primary goals of continued therapy.

Treatment Schedule

Patient received 8 packs of umbilical cord derived stem cell (UCMSC) by intravenous (IV) injection and intrathecal injection via lumbar puncture (LP), as per the schedule below:

Number Date Cell Type Delivery Method Side Effects
1 2023-09-18 UCMSC Intrathecal Injection &
Intravenous Injection
none reported
2 2023-09-22 UCMSC Intrathecal Injection &
Intravenous Injection
none reported
3 2023-09-26 UCMSC Intrathecal Injection &
Intravenous Injection
none reported
4 2023-09-26 UCMSC Intrathecal Injection &
Intravenous Injection
none reported

Condition 1 month after treatment

Since receiving treatment, the patient has shown multiple gains in general awareness, independence, and understanding, with specific areas of physical and behavioral improvement noted. Quality of life has seen moderate improvements, which the parents find satisfactory, and they report continued positive changes. While there have been no new diagnoses or illnesses, various behavioral and physical symptoms have seen either significant, moderate, or small improvements, with no reported regressions in any symptom.

Symptom Parents’ Assessment of Improvement
Aware of danger Moderate improvement
Aware of environment Moderate improvement
Comfortable with physical contact Moderate improvement
Concentration Moderate improvement
Constipation/diarrhoea Significant improvement
Cooperation with others Moderate improvement
Interest in others Moderate improvement
Over/under eating Moderate improvement
Responding to commands Moderate improvement
Sleep disturbance Moderate improvement

Condition 3 months after treatment

Three months post-treatment, the patient continues to show significant improvements, particularly in coordination, balance, and general quality of life. Notably, the patient no longer requires noise-canceling headphones and shows greater engagement with family activities. While speech development remains a challenge, improvements in overall awareness and comfort in social settings have been observed. The patient’s parents report continued satisfaction with the treatment’s outcomes, though specific verbal gains are still a goal. Importantly, there have been no adverse developments or regressions in existing symptoms, and no new health concerns have arisen.

Symptom Parents’ Assessment of Improvement
Appropriate facial expressions Moderate improvement
Aware of danger Moderate improvement
Concentration Moderate improvement
Constipation/diarrhoea Significant improvement
Cooperation with others Moderate improvement
Expressing own needs Moderate improvement
Interaction with others Moderate improvement
Interest in others Moderate improvement
Responding to commands Moderate improvement
Showing imagination Moderate improvement